Literature DB >> 16810960

SERUM HAPTOGLOBINS IN HAEMOLYTIC STATES.

J A Owen1, G C de Gruchy, H Smith.   

Abstract

Serum haptoglobin levels have been studied in patients with a number of haemolytic disorders. In general, serum haptoglobins were low in patients with increased haemolysis. Values were reduced irrespective of whether haemolysis occurred intravascularly or extravascularly. The reduction was related to the amount of haemoglobin destroyed per day. Serum haptoglobins may be raised in certain neoplasms and infections and during adrenocortical steroid hormone therapy. A rise in haptoglobins due to one of these factors may mask a fall due to haemolysis. Thus a normal or raised serum haptoglobin does not necessarily exclude a haemolytic process.

Entities:  

Year:  1960        PMID: 16810960      PMCID: PMC480125          DOI: 10.1136/jcp.13.6.478

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  The haptoglobin content of serum in haemolytic anaemia.

Authors:  I BRUS; S M LEWIS
Journal:  Br J Haematol       Date:  1959-10       Impact factor: 6.998

2.  A simple method for the determination of serum haptoglobins.

Authors:  J A OWEN; F C BETTER; J HOBAN
Journal:  J Clin Pathol       Date:  1960-03       Impact factor: 3.411

3.  Plasma hemoglobin-binding capacity in sickle cell disease.

Authors:  W LATHEM; W N JENSEN
Journal:  Blood       Date:  1959-09       Impact factor: 22.113

4.  Human serum bilirubin; an immediate method of determination and its application to the establishment of normal values.

Authors:  J E O'HAGAN; T HAMILTON; E G LE BRETON; A E SHAW
Journal:  Clin Chem       Date:  1957-10       Impact factor: 8.327

5.  The demonstration of intravascular haemolysis by means of serum paper electrophoresis and a modification of Schumm's reaction.

Authors:  F C NEALE; G M ABER; B E NORTHAM
Journal:  J Clin Pathol       Date:  1958-05       Impact factor: 3.411

6.  The genetical and clinical significance of the haptoglobins.

Authors:  A C ALLISON
Journal:  Proc R Soc Med       Date:  1958-08

7.  Haptoglobin determination in diagnosis of haemolytic diseases.

Authors:  B F NOSSLIN; M NYMAN
Journal:  Lancet       Date:  1958-05-10       Impact factor: 79.321

8.  The use of radioactive chromium (51Cr) in clinical medicine.

Authors:  H CRAWFORD; G C DE GRUCHY
Journal:  Med J Aust       Date:  1958-05-17       Impact factor: 7.738

9.  Erythrokinetics: quantitative measurements of red cell production and destruction in normal subjects and patients with anemia.

Authors:  E R GIBLETT; D H COLEMAN; G PIRZIOBIROLI; D M DONOHUE; A G MOTULSKY; C A FINCH
Journal:  Blood       Date:  1956-04       Impact factor: 22.113

10.  [Seromucoids in blood: relation to mucoproteins of the ground substance of connective tissue].

Authors:  M F JAYLE; G BOUSSIER
Journal:  Expos Annu Biochim Med       Date:  1955
  10 in total
  6 in total

1.  Differential diagnosis of fever in systemic lupus erythematosus using discriminant analysis.

Authors:  T Inoue; T Takeda; S Koda; N Negoro; M Okamura; K Amatsu; M Kohno; T Horiguchi; Y Kanayama
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

Review 2.  [Clinical significance of haptoglobin].

Authors:  H J Braun
Journal:  Blut       Date:  1972-02

3.  [Clinical significance of quantitative serum hemopexin assessment as compared with that of haptoglobin].

Authors:  H J Braun; F W Aly
Journal:  Klin Wochenschr       Date:  1971-04-15

4.  Evaluation of haptoglobin phenotype 0-0 in cirrhotic and non-cirrhotic hospital populations.

Authors:  M Nandi; G P Lewis; H Jick; D Slone; S Shapiro; V Siskind
Journal:  J Clin Pathol       Date:  1970-11       Impact factor: 3.411

5.  Serum haptoglobin in liver disease.

Authors:  R WILLIAMS; B E SPEYER; B H BILLING
Journal:  Gut       Date:  1961-12       Impact factor: 23.059

6.  CHANGES IN SERUM ALPHA-2 GLOBULINS IN RETICULOSES.

Authors:  J S MALPAS; G H FAIRLEY
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.